Clinical Trials Browser

Phase 1/2 × Advanced Refractory Solid Tumors × regorafenib × Clear all

NCT04200404 2022-05-06

A Study of CS1001 in Combination With Regorafenib in Patients With Advanced or Refractory Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Advanced Refractory Solid Tumors